LEVERKUSEN, Germany, Feb 28 (Reuters) - German drugmaker Bayer lifted its estimate of the peak sales potential of its five most important drugs to at least 7.5 billion euros ($1.03 billion), up from at least 5.5 billion euros previously.
The estimate covers the anti-clotting drug Xarelto, eye drug Eylea, cancer drugs Stivarga and Xofigo as well as lung drug Adempas, which between them generated sales of 1.5 billion euros in 2013, Bayer said on Friday.
Costco made buying a gold bar as simple as tossing it in a shopping cart. Adam Xi, 33 years old, called five different dealers to get a price he could accept for the gold bar he bought at Costco in October. Costco shoppers are spending as much as $200 million monthly on gold, according to a Wells Fargo estimate.
Super Micro Computer's lack of a preliminary earnings report led to a bloodbath in the sector.
Two more property insurance companies are pulling out of California, leaving more homeowners in the state facing loss of coverage and surging premiums as insurers flee.
The S&P 500 could bottom out in the next month, according to Fundstrat's head of research Tom Lee.
Super Micro stock fell hard after the data-center computer specialist didn't announce preliminary results for its fiscal Q3.
The high-flying sector caught a bit of gloom at the end of the week due to several discouraging developments.
One of the fastest-growing utility stocks, along with "Wall Street's Greatest Dividend Stock," make for phenomenal buys right now.
Shares of Truth Social's parent rose in another volatile session, extending a roller-coaster stretch of trading for Donald Trump's social-media startup. On Thursday, Trump Media Chief Executive Devin Nunes sent a letter to Nasdaq CEO Adena Friedman asking her to help prevent illegal naked short selling and to make sure trading firms disclose their short positions.
Magnificent Seven stocks, including AI leader Nvidia, are among the best stocks to buy and watch in today's stock market.
In the chaos of the 2008 recession, perhaps no bank stood more prepared than Jamie Dimon's J.P Morgan Chase & Co. (NYSE:JPM). In advance of the crisis, Jamie Dimon realized that "underwriting standards were deteriorating across the industry," with late payments on subprime loans rising. In late 2006, the bank led his firm to exit Wall Street's hot subprime business, starting with a frantic call made to J.P. Morgan's vacationing Chief of Securitized Products where he said, "I really want you to w